Exhibit 5.1

 

 

November 13, 2026

InspireMD, Inc.

6303 Waterford District Drive, Suite 215

Miami, Florida 33126

 

Re: Offering of Securities

 

Ladies and Gentlemen:

 

We have acted as counsel to InspireMD, Inc., a Delaware corporation (the “Company”), in connection with the offering by the Company of (i) up to 15,996,154 shares (the “Shares”) of its common stock, par value $0.0001 per share (“Common Stock”), which includes up to 8,653,846 Shares that may be sold pursuant to the exercise of an over-allotment option granted to the representative of the underwriters, (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 59,003,846 shares of Common Stock, which includes Pre-Funded Warrants to purchase up to 8,653,846 shares of Common Stock that may be sold pursuant to the exercise of an over-allotment option granted to the representative of the underwriters, and (iii) Series L warrants (the “Series L Warrants” and, together with the Pre-Funded Warrants, the “Warrants”) to purchase up to 49,759,615 shares of Common Stock, which includes Series L Warrants to purchase up to 6,490,384 that may be sold pursuant to the exercise of an over-allotment option granted to the representative of underwriters. This opinion also covers (i) pre-funded warrants to purchase up to 43,269,231 shares of Common Stock that may be issued in lieu of shares of Common Stock upon the exercise of Series L Warrants at the election of the holder (the “Series L Pre-Funded Warrants”) and (ii) Series L Pre-Funded Warrants to purchase up to 6,490,384 shares of Common Stock that may be issued in lieu of shares of Common Stock upon the exercise of Series L Warrants at the election of the holder that may be sold pursuant to the exercise of an over-allotment option granted to the representative of the underwriters. The shares of Common Stock issuable upon exercise of the Warrants and the Series L Pre-Funded Warrants are referred to herein as the “Warrant Shares.” The Shares, the Warrants, the Series L Pre-Funded Warrants and the Warrant Shares are being offered pursuant to a Registration Statement on Form S-3 (No. 333-286309) (the “Registration Statement”), filed with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), the base prospectus, dated April 10, 2025, included in the Registration Statement (the “Base Prospectus”), and the prospectus supplement relating to the Shares, the Warrants and the Warrant Shares, dated November 13, 2026, will be filed with the Commission pursuant to Rule 424(b) under the Securities Act (together with the Base Prospectus, the “Prospectus”).

 

In rendering our opinions set forth below, we have examined and relied upon (a) the Registration Statement and the Prospectus, (b) the underwriting agreement, dated as of November 13, 2026, between the Company and Lake Street Capital Markets, LLC, as representative of the several underwriters named therein (the “Underwriting Agreement”), (c) the forms of the Pre-Funded Warrants and the Series L Warrants, each filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Commission on the date hereof, (d) resolutions of the Company’s board of directors and the pricing committee thereof relating to the offering, (e) the Company’s certificate of incorporation and bylaws, each as amended and currently in effect, and (f) originals or copies certified to our satisfaction of such records, documents, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinions expressed below. In our examination, we have assumed: (i) the authenticity of original documents and the genuineness of all signatures; (ii) the conformity to the originals of all documents submitted to us as copies; (iii) the truth, accuracy and completeness of the information, representations and warranties contained in the instruments, documents, certificates and records we have reviewed; and (iv) the legal capacity for all purposes relevant hereto of all natural persons and, with respect to all parties to agreements or instruments relevant hereto other than the Company, that such parties had the requisite power and authority (corporate or otherwise) to execute, deliver and perform such agreements or instruments, that such agreements or instruments have been duly authorized by all requisite action (corporate or otherwise), executed and delivered by such parties and that such agreements or instruments are the valid, binding and enforceable obligations of such parties. As to any facts material to the opinions expressed herein that were not independently established or verified, we have relied upon oral or written statements and representations of officers and other representatives of the Company.

 

With regard to our opinion as to the Warrants, the Series L Pre-Funded Warrants and the Warrant Shares, we have assumed that, at the time of exercise, a sufficient number of shares of Common Stock will be authorized and available for issuance under the Company’s certificate of incorporation as then in effect, and we express no opinion to the extent that future issuances of securities of the Company, antidilution adjustments to outstanding securities of the Company or other matters cause the Warrants or the Series L Pre-Funded Warrants to be exercisable for more shares of Common Stock than the number available for issuance by the Company or that the consideration paid upon exercise of the Warrants or the Series L Pre-Funded Warrants is below the par value of the Common Stock.

 

 

 

 

Our opinion herein is expressed solely with respect to the General Corporation Law of the State of Delaware and, as to the Warrants and the Series L Pre-Funded Warrants constituting binding obligations of the Company, the laws of the State of New York. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation.

 

With regard to our opinion concerning the Warrants and the Series L Pre-Funded Warrants constituting binding obligations of the Company:

 

(i) Our opinion is subject to, and may be limited by, (a) applicable bankruptcy, reorganization, insolvency, moratorium, fraudulent conveyance, debtor and creditor, and similar laws which relate to or affect creditors’ rights generally, and (b) general principles of equity (including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing) regardless of whether considered in a proceeding in equity or at law;

 

(ii) Our opinion is subject to the qualification that (a) the enforceability of provisions for indemnification or limitations on liability may be limited by applicable law and by public policy considerations, and (b) the availability of specific performance, an injunction or other equitable remedies is subject to the discretion of the court before which the request is brought;

 

(iii) We express no opinion with respect to any provision of the Warrants that: (a) relates to the subject matter jurisdiction of any federal court of the United States of America or any federal appellate court to adjudicate any controversy related to the Warrants; (b) specifies provisions may be waived in writing, to the extent that an oral agreement or implied agreement by trade practice or course of conduct has been created that modifies such provision; (c) contains a waiver of an inconvenient forum; (d) provides for liquidated damages, default interest, late charges, monetary penalties, prepayment or make-whole payments or other economic remedies; (e) relates to advance waivers of claims, defenses, rights granted by law, or notice, opportunity for hearing, evidentiary requirements, statutes of limitations, trial by jury, service of process or procedural rights; (f) restricts non-written modifications and waivers; (g) provides for the payment of legal and other professional fees where such payment is contrary to law or public policy; (h) relates to exclusivity, election or accumulation of rights or remedies; or (i) provides that provisions of the Warrants are severable to the extent an essential part of the agreed exchange is determined to be invalid and unenforceable; and

 

(iv) We express no opinion as to whether a state court outside of the State of New York or a federal court of the United States would give effect to the choice of New York law or jurisdiction provided for in the Warrants.

 

On the basis of the foregoing, and in reliance thereon, we are of the opinion that (i) the Shares, when sold and issued against payment therefor in accordance with the Underwriting Agreement, the Registration Statement and the Prospectus, will be validly issued, fully paid and nonassessable shares of Common Stock, (ii) the Warrants, when duly executed and delivered by the Company against payment therefor in accordance with the Underwriting Agreement, the Registration Statement and the Prospectus, will be binding obligations of the Company, (iii) the Series L Pre-Funded Warrants, when duly executed and delivered by the Company upon exercise of the Series L Warrants in accordance with their terms, including payment of the applicable exercise price, will be binding obligations of the Company, and (iv) the Warrant Shares, when issued and paid for in accordance with the terms of the Warrants or the Series L Pre-Funded Warrants, as applicable, will be validly issued, fully paid and nonassessable shares of Common Stock.

 

This opinion is limited to the matters expressly set forth in this letter, and no opinion has been or should be implied, or may be inferred, beyond the matters expressly stated. This opinion speaks only as to law and facts in effect or existing as of the date hereof, and we have no obligation or responsibility to update or supplement this letter to reflect any facts or circumstances that may hereafter come to our attention or any changes in law that may hereafter occur.

 

We consent to the reference to our firm under the caption “Legal Matters” in the Prospectus and to the filing of this opinion as an exhibit to a Current Report on Form 8-K to be filed with the Commission for incorporation by reference into the Registration Statement. In giving such consents, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.

 

 

  Very truly yours,
   
  /s/ Greenberg Traurig, LLP
  GREENBERG TRAURIG, LLP